International multicenter randomized, placebo-controlled phase III clinical trial of β-d-mannuronic acid in rheumatoid arthritis patients
Articolo
Data di Pubblicazione:
2019
Tipologia CRIS:
14.a.1 Articolo su rivista
Keywords:
Clinical III trial; DMARDs; M2000; Mannuronic acid; NSAIDs; Rheumatoid arthritis; Immunology; Pharmacology; Pharmacology (medical)
Elenco autori:
Rezaieyazdi, Zahra; Farooqi, Abid; Soleymani-Salehabadi, Hossein; Ahmadzadeh, Arman; Aslani, Mona; Omidian, Saiedeh; Sadoughi, Arezoo; Vahidi, Zohreh; Khodashahi, Mandana; Zamurrad, Shazia; Mortazavi-Jahromi, Seyed Shahabeddin; Fallahzadeh, Hossein; Hosseini, Mostafa; Aghazadeh, Zahra; Ekhtiari, Parvin; Matsuo, Hidenori; Rehm, Bernd H. A.; Cuzzocrea, Salvatore; D’Aniello, Antimo; Mirshafiey, Abbas
Link alla scheda completa:
Pubblicato in: